Neurophyxia B.V. is an innovative drug development company which focuses on disorders affecting the newborn child. The lead product, 2-iminobiotin (2-IB), addresses the devastating effects of oxygen shortage at birth (perinatal asphyxia) .
| Website | http://neurophyxia.com |
| Revenue | $3 million |
| Employees | 3 (0 on RocketReach) |
| Address | PO Box 3061, s Hertogenbosch, NL |
| Phone | +31 73 624 2141 |
| Industry | Manufacturing General, Biotechnology, Manufacturing, Science and Engineering |
| Keywords | Brain Injury Recovery |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Neurophyxia employee's phone or email?
Neurophyxia Questions
The Neurophyxia annual revenue was $3 million in 2026.
The NAICS codes for Neurophyxia are [325, 32541, 3254, 32].
The SIC codes for Neurophyxia are [28, 283].
G2Crowd Trusted
300K+
Plugin Users
